Correlation Between Regenxbio and Cytodyn
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Cytodyn at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Cytodyn into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Cytodyn, you can compare the effects of market volatilities on Regenxbio and Cytodyn and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Cytodyn. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Cytodyn.
Diversification Opportunities for Regenxbio and Cytodyn
Poor diversification
The 3 months correlation between Regenxbio and Cytodyn is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Cytodyn in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytodyn and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Cytodyn. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytodyn has no effect on the direction of Regenxbio i.e., Regenxbio and Cytodyn go up and down completely randomly.
Pair Corralation between Regenxbio and Cytodyn
Given the investment horizon of 90 days Regenxbio is expected to generate 0.99 times more return on investment than Cytodyn. However, Regenxbio is 1.01 times less risky than Cytodyn. It trades about -0.05 of its potential returns per unit of risk. Cytodyn is currently generating about -0.05 per unit of risk. If you would invest 1,148 in Regenxbio on September 6, 2024 and sell it today you would lose (218.00) from holding Regenxbio or give up 18.99% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Regenxbio vs. Cytodyn
Performance |
Timeline |
Regenxbio |
Cytodyn |
Regenxbio and Cytodyn Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regenxbio and Cytodyn
The main advantage of trading using opposite Regenxbio and Cytodyn positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Cytodyn can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytodyn will offset losses from the drop in Cytodyn's long position.Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
Cytodyn vs. Madrigal Pharmaceuticals | Cytodyn vs. Scpharmaceuticals | Cytodyn vs. Akero Therapeutics | Cytodyn vs. Cardiff Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |